Skip to content

Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery

A Prospective, Randomized Controlled Study to Compare the Effect of Sevoflurane and Propofol for Maintenance of Anesthesia on Postoperative Recovery After Transsphenoidal Resection of Pituitary Adenoma

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05822817
Enrollment
252
Registered
2023-04-21
Start date
2023-05-03
Completion date
2024-08-14
Last updated
2025-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pituitary Adenoma

Keywords

Anesthesia, Transsphenoidal surgery, Enhanced recovery after surgery

Brief summary

Currently, total intravenous anesthesia (TIVA) and inhaled anesthesia are both commonly used for transsphenoidal pituitary adenoma resection. However, optimal choice for anesthesia maintenance in transsphenoidal surgery remains unclear. Previous studies focusing on this question provided fragmentary assessment and controversial results. The goal of this clinical trial is to investigate whether propofol and sevoflurane have different effect on post-anesthetic recovery after transsphenoidal resection of pituitary adenoma.

Interventions

DRUGsevoflurane

Anesthesia is maintained with inhalation of sevoflurane. The concentration of sevoflurane was adjusted to maintain anesthetic depth, aiming for a bispectral index of 40-60.

DRUGpropofol

Anesthesia is maintained with an effect-site target-controlled infusion of propofol (2-6ug/ml) based on the Marsh mode. The concentration of propofol was adjusted to maintain anesthetic depth, aiming for a bispectral index of 40-60.

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Men or women, aged from 18 to 70 2. American Society of Anesthesiologists (ASA) class I - III 3. Patients scheduled for transsphenoidal surgery requiring general anesthesia managed with endotracheal intubation

Exclusion criteria

1. Patients allergic or contraindicated to sevoflurane, propofol, or other drugs used during surgery 2. Severe pulmonary disease, saturation of peripheral oxygen (SpO2) \< 90% 3. Severe nervous system disease with consciousness disorder 4. Patients scheduled for intensive care unit (ICU) after surgery 5. Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
15-item quality of recovery score (QoR-15)24 hours after end of surgeryThe QoR-15 score ranges from 0 to 150 (higher is better). The investigators record the scores of two groups 1 day after the surgery.

Secondary

MeasureTime frameDescription
Agitation or sedation level during emergenceFrom stopping sevoflurane or propofol to complete awakening, approximately 30 minutesThe highest Richmond agitation and sedation scale score (RASS) during emergence. The RASS score ranges from -5 to +4, and a lower score indicates a more sedative level.
PACU antiemetic drug useFrom admit into PACU to discharge from PACU, approximately 45 minutesThe drug use due to postoperative nausea and vomiting in PACU.
Concentration of serum adrenocorticotropic hormone (ACTH)24 hours after end of surgeryThe investigators examine the serum level of ACTH in pg/mL.
Concentration of serum cortisol24 hours after end of surgeryThe investigators examine the serum level of cortisol in ug/dL.
Concentration of serum thyroid-stimulating hormone (TSH)24 hours after end of surgeryThe investigators examine the serum level of TSH in uIU/mL.
Concentration of serum growth hormone (GH)24 hours after end of surgeryThe investigators examine the serum level of GH in ng/mL.
Concentration of serum gonadotrophin24 hours after end of surgeryThe investigators examine the serum level of gonadotrophin in IU/L.
Concentration of serum prolactin (PRL)24 hours after end of surgeryThe investigators examine the serum level of PRL ng/mL.
Counts of peripheral blood lymphocyte24 hours after end of surgery
Incidence of hypotension during anesthesiaFrom start of surgery to end of surgery, on an average of 2 hoursHypotension is defined as decrease of mean arterial pressure (MAP) more than 20% of baseline.
Incidence of hypertension during anesthesiaFrom start of surgery to end of surgery, on an average of 2 hoursHypertension is defined as increase of MAP more than 20% of baseline.
Time to discharge from hospitalFrom end of surgery to discharge from hospital, on an average of 2 daysThe time between end of surgery and discharge from hospital.
PACU analgesic drug useFrom admit into PACU to discharge from PACU, approximately 45 minutesThe drug use due to postoperative pain in PACU.
Post operative nausea and vomiting score24 hours after end of surgeryScore: 0, no nausea and vomiting; 1-4, mild nausea and vomiting; 5-6, moderate nausea and vomiting; 7-10, severe nausea and vomiting.
Time to awake from anesthesiaFrom stopping sevoflurane or propofol to awake, approximately 30 minutesThe time between discontinuing drugs and response to verbal command.
Time to extubationFrom stopping sevoflurane or propofol to recovery of spontaneous breathing and withdrawal of tracheal tube, approximately 30 minutesThe time between discontinuing drugs and withdrawal of tracheal tube.
Coughing and bucking during emergenceFrom stopping sevoflurane or propofol to complete awakening, approximately 30 minutesCoughing score ranges from 0 to 3, and a higher score indicates a severer outcome.The investigators record the highest coughing score during emergence.
Time to discharge from postanesthesia care unit (PACU)From admit into PACU to discharge from PACU, approximately 45 minutesThe time between admission into PACU and discharging from PACU with Aldrete score over 9. Aldrete score ranges from 0 to 10, and a higher score indicates a better recovery from anesthesia.

Other

MeasureTime frameDescription
Post operative nausea and vomiting score at postoperative day 77 days after the surgeryScore: 0, no nausea and vomiting; 1-4, mild nausea and vomiting; 5-6, moderate nausea and vomiting; 7-10, severe nausea and vomiting.
Sleep quality score at postoperative day 77 days after the surgeryThe investigators record the sleep quality score (0 to 10, higher the better) of patients on the 7th day after the surgery by telephone follow-up.
Appetite score at postoperative day 77 days after the surgeryThe investigators record the appetite score (0 to 10, higher the better) of patients on the 7th day after the surgery by telephone follow-up.
30-day readmissionAt the 1st postoperative monthThe investigators record the patients' readmission to our hospital due to any pathological reason (to outpatient or inpatient).
Concentration of serum cortisolAt the 3rd postoperative monthThe investigators examine the serum level of cortisol in ug/dL.
Concentration of serum growth hormone (GH)At the 3rd postoperative monthThe investigators examine the serum level of GH in ng/mL.
Concentration of serum gonadotrophinAt the 3rd postoperative monthThe investigators examine the serum level of gonadotrophin in IU/L.
Concentration of serum thyroid-stimulating hormone (TSH)At the 3rd postoperative monthThe investigators examine the serum level of TSH in uIU/mL.
Concentration of serum prolactin (PRL)At the 3rd postoperative monthThe investigators examine the serum level of PRL ng/mL.
Number of participants with postoperative complicationsAfter the surgery till dischargeThe investigators record major postoperative complications and other complications related to anesthesia not mentioned above.
Numerical rating scale (NRS) pain score at postoperative day 77 days after the surgeryThe investigators record NRS pain score (0 to 10, higher the more painful) of patients on the 7th day after the surgery by telephone follow-up.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026